Kendall C. Shibuya

Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment

Kendall C. Shibuya, Vikas Goel, Wei Xiong et al. · PLoS ONE · 2014 · 122 citations · Full text

Life Sciences, Immunology, Oncology +17

T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression

Aude G. Chapuis, Ilana M. Roberts, John A. Thompson et al. · Journal of Clinical Oncology · 2016 · 116 citations · Full text

Life Sciences, Immunology, Oncology +17

Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I

Aude G. Chapuis, Olga K. Afanasiev, Jayasri G. Iyer et al. · Cancer Immunology Research · 2013 · 97 citations

Life Sciences, Immunology, Oncology +17

Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient

Aude G. Chapuis, Sylvia M. Lee, John A. Thompson et al. · The Journal of Experimental Medicine · 2016 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells

Seth M. Pollack, Robin L. Jones, Erik Farrar et al. · Journal for ImmunoTherapy of Cancer · 2014 · 64 citations · Full text

Life Sciences, Immunology, Oncology +14